DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the POLY MEDICURE LIMITED (POLYMED) share price today?

POLY MEDICURE LIMITED (POLYMED) is trading at ₹1,680.5 on the NSE, down 2.45% on the day. Source: DocStoX.

What is the PE ratio of POLY MEDICURE LIMITED?

POLY MEDICURE LIMITED has a price-to-earnings (PE) ratio of 52.9 in the Healthcare sector.

What is the market capitalisation of POLY MEDICURE LIMITED?

POLY MEDICURE LIMITED has a market capitalisation of approximately ₹17,033 crore.

POLY MEDICURE LIMITED

POLYMED·NSE·Healthcare

₹1,680.50▼ -42.20 (-2.45%)

Healthcare · Medical Equipment

A steady, established business

NIFTY 500NIFTY SMALLCAP 250

Day₹1667.10

₹1739.00

52W₹1182

₹214552%

Open

₹1726.00

High

₹1739.00

Low

₹1667.10

Prev Close

₹1722.70

Volume

84.1K

VWAP

₹1690.71

Snapshot

Key fundamentals

Market Cap

₹17,033 Cr

P/E Ratio

52.88Expensive

P/B Ratio

5.66

EPS

₹31.78

Book Value

₹306.00

ROE

11.20%Average

ROCE

14.00%Decent

Dividend Yield

0.21%

Debt / Equity

0.11Low

Face Value

₹5.00

52W High

₹2144.90

52W Low

₹1182.00

Sector

Healthcare

Industry

Medical Equipment

Avoid

None moatHigh uncertainty

Fair value estimate

₹340

▼ 79.7%downside

Trading at ₹1,681 — 80% above our estimate

BearFair valueBull

₹289₹340₹468

/100

Business quality — Solid

Growth 81Profitability 58Efficiency 15Valuation 47

Plain English

Our view

A steady, established business
Low debt relative to equity
Fundamental red flags (Piotroski 1/9)

Strengths

Low debt relative to equity
Revenue compounding 19% over 3 years
Profit growing 21% a year
Promoters hold a controlling stake

Risks

Fundamental red flags (Piotroski 1/9)

How we got there

Fair value methods

Residual income

11% ROE fading to 12% over ~3 yrs, on ₹306 book

₹305

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹468

Analyst target

No analyst coverage

—

Blended fair value₹340

What the numbers say

Investment thesis

Bull case

Low debt relative to equity
Revenue compounding 19% over 3 years
Profit growing 21% a year
Promoters hold a controlling stake

Bear case

Fundamental red flags (Piotroski 1/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

52.9Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

11.2%Average

Above 15% is considered healthy for Indian equities

ROCE

14.0%Decent

Above 18% means capital is working hard

Debt/Eq

0.11Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹17,033 Cr

P/B

5.66

EPS

₹31.78

Div Yield

0.21%

What changed

Recent changes

Foreign investors-3.5% stake last quarter
Domestic institutions+1.8% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 52.9×

Growth

Strong

+19% rev CAGR

Profitability

Modest

11.2% ROE

Financial health

Rock solid

D/E 0.11

Momentum

N/A

No technicals

Today

Trading activity

Delivery %43.8%

Turnover₹1421.38L Cr

Trades13,379

VWAP₹1690.71

Face value₹5.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+18.9%

+19.0%

10Y

+16.4%

Profit

+21.5%

+18.7%

10Y

+20.9%

EPS

+19.4%

+17.5%

10Y

+19.2%

Profile

Pros

Company has delivered good profit growth of 19.4% CAGR over last 5 years

Watch-outs

Cons

Debtor days have increased from 83.8 to 103 days.
Working capital days have increased from 126 days to 249 days

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Foreign investors sold 3.49 pts; domestic institutions added 1.75 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

62%

Promoter

Promoters

62.4%0.00

Public

12.6%+1.31

FII / FPI

5.9%-3.49

DII

15.6%+1.75

Others

3.5%

Total shareholders

73,414+5,664 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter62.42%

FII5.91%

DII15.59%

Public12.61%

Others3.47%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Poly Medicure Limited is an India-based manufacturer and exporter of medical devices. The Company exports plastic medical disposables/surgical devices.[1]